TGA
ELV icon

TPG GP A’s Elevance Health ELV Stock Holding History

TPG GP A’s Portfolio ELV Stock Details ELV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		– Sell
-360,557
Closed -$195M – 36
2024
Q2 		$195M Sell
360,557
-89,853
-20% -$47.5M 3.04% 7
2024
Q1 		$234M Sell
450,410
-111,320
-20% -$55.4M 4.47% 5
2023
Q4 		$265M Buy
561,730
+20,284
+4% +$9.38M 4.27% 6
2023
Q3 		$236M Buy
541,446
+60,732
+13% +$27.5M 4.07% 7
2023
Q2 		$214M Sell
480,714
-1,808
-0.4% -$834K 3.14% 9
2023
Q1 		$222M Buy
482,522
+43,940
+10% +$20.9M 3.62% 10
2022
Q4 		$225M Sell
438,582
-187,183
-30% -$95M 4.42% 6
2022
Q3 		$284M Sell
625,765
-70,675
-10% -$33.8M 4.66% 6
2022
Q2 		$336M Sell
696,440
-84,274
-11% -$41.7M 5.19% 7
2022
Q1 		$384M Sell
780,714
-142,399
-15% -$65.1M 4.74% 5
2021
Q4 		$428M Buy
+923,113
New +$388M 4.27% 7

Other funds holding ELV

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Sanders Capital
Sanders Capital West Palm Beach, Florida $83.9B AUM 37.89% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return

TPG GP A's ELV Position: Q3 2024 in Review

TPG GP A sold out of Elevance Health (ELV) in Q3 2024, closing a stake of 360,557 shares — an estimated $195M sold.

TPG GP A first reported a position in ELV in Q4 2021 and held it in 11 quarters. The position peaked at $428M in Q4 2021. 1,693 funds tracked by Wall St. Rank hold ELV as of Q3 2024.

  • TPG GP A reported no remaining Elevance Health position as of Q3 2024 after selling out during the quarter.
  • TPG GP A sold 360,557 Elevance Health shares in Q3 2024, an estimated $195M.
  • TPG GP A first reported a position in Elevance Health in Q4 2021 and held it in 11 quarters.
  • TPG GP A's Elevance Health position peaked at $428M in Q4 2021.
  • 1,693 funds tracked by Wall St. Rank held Elevance Health as of Q3 2024.

Based on TPG GP A's 13F filing for Q3 2024, filed 14 Nov 2024.